Item Type | Name |
Concept
|
Antipsychotic Agents
|
Concept
|
Codon, Terminator
|
Concept
|
Adaptor Proteins, Signal Transducing
|
Concept
|
Intellectual Disability
|
Concept
|
Gemfibrozil
|
Concept
|
G(M1) Ganglioside
|
Concept
|
Lymphocytes
|
Concept
|
Reflex, Startle
|
Concept
|
Longitudinal Studies
|
Concept
|
Mitochondrial Myopathies
|
Concept
|
Movement
|
Concept
|
Enkephalin, Leucine
|
Concept
|
Odds Ratio
|
Concept
|
Cerebral Amyloid Angiopathy
|
Concept
|
Apolipoprotein E4
|
Concept
|
Chromosomes, Human, X
|
Concept
|
Primary Ovarian Insufficiency
|
Concept
|
Psychomotor Performance
|
Concept
|
Parents
|
Concept
|
Fatal Outcome
|
Concept
|
Genomic Instability
|
Concept
|
Receptors, Neurotransmitter
|
Concept
|
Vesicular Transport Proteins
|
Concept
|
Alprostadil
|
Concept
|
Tandem Mass Spectrometry
|
Concept
|
Sensory Gating
|
Concept
|
Enzyme-Linked Immunosorbent Assay
|
Concept
|
Activities of Daily Living
|
Concept
|
Receptors, AMPA
|
Concept
|
Karyotyping
|
Concept
|
Disease Models, Animal
|
Concept
|
Precision Medicine
|
Concept
|
Minocycline
|
Concept
|
Receptors, Opioid, kappa
|
Concept
|
Maryland
|
Concept
|
DNA Methylation
|
Concept
|
Diagnosis, Computer-Assisted
|
Concept
|
Health Surveys
|
Concept
|
Narcotics
|
Concept
|
Speech
|
Concept
|
Anti-Bacterial Agents
|
Concept
|
PPAR alpha
|
Concept
|
Databases, Factual
|
Concept
|
Sandhoff Disease
|
Concept
|
Electrocardiography, Ambulatory
|
Concept
|
Brain Diseases, Metabolic, Inborn
|
Concept
|
Patient Selection
|
Concept
|
Body Height
|
Concept
|
Postural Balance
|
Concept
|
Matrix Attachment Region Binding Proteins
|
Concept
|
Amyloid beta-Protein Precursor
|
Concept
|
Gene Amplification
|
Concept
|
Hydroxycholesterols
|
Concept
|
Central Nervous System Stimulants
|
Concept
|
Cell Lineage
|
Concept
|
Nicotine
|
Concept
|
Monitoring, Ambulatory
|
Concept
|
Membrane Transport Proteins
|
Concept
|
Pilot Projects
|
Concept
|
Visual Perception
|
Concept
|
Humans
|
Concept
|
Psychopharmacology
|
Concept
|
Muscle Hypotonia
|
Concept
|
Likelihood Functions
|
Concept
|
Pregnancy Outcome
|
Concept
|
Memory Disorders
|
Concept
|
Membrane Glycoproteins
|
Concept
|
Receptors, GABA
|
Concept
|
Gait
|
Concept
|
Receptor, Serotonin, 5-HT1A
|
Concept
|
Neurosurgical Procedures
|
Concept
|
Chicago
|
Concept
|
Mothers
|
Concept
|
Caregivers
|
Concept
|
Food, Formulated
|
Concept
|
Ketone Bodies
|
Concept
|
Adrenergic alpha-Agonists
|
Concept
|
Long QT Syndrome
|
Concept
|
Chromosomes, Human, Pair 16
|
Concept
|
Heredodegenerative Disorders, Nervous System
|
Concept
|
Drug Eruptions
|
Concept
|
Mitochondria
|
Concept
|
DiGeorge Syndrome
|
Concept
|
Spatio-Temporal Analysis
|
Concept
|
Incidence
|
Concept
|
Magnetic Resonance Spectroscopy
|
Concept
|
Introns
|
Concept
|
Apolipoproteins E
|
Concept
|
Proportional Hazards Models
|
Concept
|
Recurrence
|
Concept
|
2-Chloroadenosine
|
Concept
|
Sphingolipids
|
Concept
|
Motor Neuron Disease
|
Concept
|
Enkephalin, Leucine-2-Alanine
|
Concept
|
Neurologic Examination
|
Concept
|
Retinoid X Receptor alpha
|
Concept
|
Neurofilament Proteins
|
Concept
|
Dopamine Agents
|
Concept
|
Magnetic Resonance Imaging
|
Concept
|
Cross-Over Studies
|
Concept
|
Sex Distribution
|
Concept
|
Trisomy
|
Concept
|
Receptors, Dopamine
|
Concept
|
Drosophila melanogaster
|
Concept
|
Neurturin
|
Concept
|
Lysosomes
|
Concept
|
Research Design
|
Concept
|
Lithium Compounds
|
Concept
|
Neurogenesis
|
Concept
|
Confidence Intervals
|
Concept
|
Genetic Testing
|
Concept
|
Demography
|
Concept
|
Neurodegenerative Diseases
|
Concept
|
Health Status
|
Concept
|
Synaptic Transmission
|
Concept
|
Adrenergic beta-Antagonists
|
Concept
|
Mice, Knockout
|
Concept
|
Minisatellite Repeats
|
Concept
|
Menopause
|
Concept
|
Feasibility Studies
|
Concept
|
Amino Acid Sequence
|
Concept
|
Binding, Competitive
|
Concept
|
Blood Cell Count
|
Concept
|
1-Methyl-3-isobutylxanthine
|
Concept
|
Autistic Disorder
|
Concept
|
Animals
|
Concept
|
Facial Expression
|
Concept
|
PPAR-beta
|
Concept
|
Epidemiologic Studies
|
Concept
|
Spinal Puncture
|
Concept
|
Double-Blind Method
|
Concept
|
Georgia
|
Concept
|
Chronic Disease
|
Concept
|
Random Allocation
|
Concept
|
Vocabulary
|
Concept
|
Methylation
|
Concept
|
Guanylyl Imidodiphosphate
|
Concept
|
Child Development
|
Concept
|
Amino Acid Substitution
|
Concept
|
Patient Acceptance of Health Care
|
Concept
|
Societies, Medical
|
Concept
|
Glial Fibrillary Acidic Protein
|
Concept
|
Syndrome
|
Concept
|
Receptor, Serotonin, 5-HT2A
|
Concept
|
8-Hydroxy-2-(di-n-propylamino)tetralin
|
Concept
|
Macrophages
|
Concept
|
Vagus Nerve
|
Concept
|
National Institutes of Health (U.S.)
|
Concept
|
Fragile X Syndrome
|
Concept
|
Serotonin
|
Concept
|
Tretinoin
|
Concept
|
Sudden Infant Death
|
Concept
|
Cricetinae
|
Concept
|
Rett Syndrome
|
Concept
|
Zinc
|
Concept
|
Arrhythmia, Sinus
|
Concept
|
Mental Retardation, X-Linked
|
Concept
|
Microsatellite Repeats
|
Concept
|
Pituitary Adenylate Cyclase-Activating Polypeptide
|
Concept
|
Down Syndrome
|
Concept
|
Receptors, Opioid
|
Concept
|
Neuronal Ceroid-Lipofuscinoses
|
Concept
|
Psychiatric Status Rating Scales
|
Concept
|
Nuclear Family
|
Concept
|
Quality-Adjusted Life Years
|
Concept
|
Language Tests
|
Concept
|
Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I
|
Concept
|
Tobacco Smoke Pollution
|
Concept
|
Trinucleotide Repeat Expansion
|
Concept
|
Sleep
|
Concept
|
ras Proteins
|
Concept
|
G(M2) Ganglioside
|
Concept
|
Neuroimaging
|
Concept
|
Reverse Transcriptase Polymerase Chain Reaction
|
Concept
|
Reaction Time
|
Concept
|
Thymus Gland
|
Concept
|
Population Surveillance
|
Concept
|
Memory
|
Concept
|
Models, Genetic
|
Concept
|
Metabolomics
|
Concept
|
Self Report
|
Concept
|
Antioxidants
|
Concept
|
Niemann-Pick Disease, Type A
|
Concept
|
Anesthetics
|
Concept
|
Auditory Perception
|
Concept
|
Cytochrome P-450 CYP1A1
|
Concept
|
Genetic Carrier Screening
|
Concept
|
Language Disorders
|
Concept
|
Interdisciplinary Communication
|
Concept
|
Alzheimer Disease
|
Concept
|
Evoked Potentials, Auditory
|
Concept
|
alpha-Fetoproteins
|
Concept
|
Glycosylphosphatidylinositols
|
Concept
|
Oligonucleotides, Antisense
|
Concept
|
Parental Consent
|
Concept
|
Infusion Pumps
|
Concept
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
|
Concept
|
Genetic Counseling
|
Concept
|
Mass Screening
|
Concept
|
Language Development Disorders
|
Concept
|
Levodopa
|
Concept
|
Infant Nutritional Physiological Phenomena
|
Concept
|
Ehlers-Danlos Syndrome
|
Concept
|
California
|
Concept
|
Rare Diseases
|
Concept
|
Infusions, Intraventricular
|
Concept
|
Patient Care Team
|
Concept
|
Fluorescent Antibody Technique
|
Concept
|
Obesity Hypoventilation Syndrome
|
Concept
|
Mitochondrial Membranes
|
Concept
|
Brefeldin A
|
Concept
|
Cholinesterase Inhibitors
|
Concept
|
Hyperkinesis
|
Concept
|
Disease Progression
|
Concept
|
Dependovirus
|
Concept
|
Fathers
|
Concept
|
Long-Term Potentiation
|
Concept
|
Pupil
|
Concept
|
Treatment Outcome
|
Concept
|
Canada
|
Concept
|
Health Knowledge, Attitudes, Practice
|
Concept
|
Mice, Inbred BALB C
|
Concept
|
Sensitivity and Specificity
|
Concept
|
Learning
|
Concept
|
Focus Groups
|
Concept
|
Sialic Acid Binding Ig-like Lectin 2
|
Concept
|
Dietary Fats
|
Concept
|
Infusions, Spinal
|
Concept
|
Memory, Short-Term
|
Concept
|
Trinucleotide Repeats
|
Concept
|
Cats
|
Concept
|
Prostaglandins E
|
Concept
|
DNA, Complementary
|
Concept
|
Registries
|
Concept
|
Polymorphism, Single Nucleotide
|
Concept
|
Cohort Studies
|
Concept
|
Antibodies
|
Concept
|
Ubiquitin Thiolesterase
|
Concept
|
Databases, Genetic
|
Concept
|
Hypoventilation
|
Concept
|
Electromyography
|
Concept
|
Death, Sudden
|
Concept
|
Calcium
|
Concept
|
Adenylyl Cyclases
|
Concept
|
Chromosomes, Human, Pair 4
|
Concept
|
Hydrogen Peroxide
|
Concept
|
Iron Overload
|
Concept
|
Receptors, Serotonin
|
Concept
|
Blotting, Western
|
Concept
|
Tuberous Sclerosis
|
Concept
|
Injections, Spinal
|
Concept
|
Cerebellar Ataxia
|
Concept
|
Ascorbic Acid
|
Concept
|
Tunicamycin
|
Concept
|
Polysomnography
|
Concept
|
Ataxia
|
Concept
|
Prevalence
|
Concept
|
Case-Control Studies
|
Concept
|
Lewy Body Disease
|
Concept
|
Baroreflex
|
Concept
|
Drosophila Proteins
|
Concept
|
Tracheotomy
|
Concept
|
Induced Pluripotent Stem Cells
|
Concept
|
Gait Ataxia
|
Concept
|
Microfilament Proteins
|
Concept
|
Extracellular Signal-Regulated MAP Kinases
|
Concept
|
Predictive Value of Tests
|
Concept
|
Reproducibility of Results
|
Concept
|
Clergy
|
Concept
|
Ovary
|
Concept
|
Diseases in Twins
|
Concept
|
New York
|
Concept
|
Prospective Studies
|
Concept
|
Phosphodiesterase 4 Inhibitors
|
Concept
|
Electron Transport
|
Concept
|
Reflex, Pupillary
|
Concept
|
3' Untranslated Regions
|
Concept
|
Psychotropic Drugs
|
Concept
|
Cross-Sectional Studies
|
Concept
|
Rats
|
Concept
|
Amniocentesis
|
Concept
|
Limit of Detection
|
Concept
|
Least-Squares Analysis
|
Concept
|
Niemann-Pick Disease, Type C
|
Concept
|
PPAR gamma
|
Concept
|
Staining and Labeling
|
Concept
|
Receptor, trkB
|
Concept
|
Codon, Nonsense
|
Concept
|
Infant, Newborn
|
Concept
|
In Situ Hybridization
|
Concept
|
Randomized Controlled Trials as Topic
|
Concept
|
Tremor
|
Concept
|
Lysergic Acid
|
Concept
|
Agenesis of Corpus Callosum
|
Concept
|
Brain Waves
|
Concept
|
Genome-Wide Association Study
|
Concept
|
Ganglioneuroblastoma
|
Concept
|
Enzyme Replacement Therapy
|
Concept
|
Chromosome Aberrations
|
Concept
|
Tyrosine 3-Monooxygenase
|
Concept
|
Surveys and Questionnaires
|
Concept
|
Pantothenate Kinase-Associated Neurodegeneration
|
Concept
|
Enzyme Inhibitors
|
Concept
|
Neural Inhibition
|
Concept
|
Myotonic Dystrophy
|
Concept
|
Walking
|
Concept
|
Hallucinations
|
Concept
|
Chromosome Deletion
|
Concept
|
Oligonucleotide Array Sequence Analysis
|
Concept
|
Regression Analysis
|
Concept
|
Asymptomatic Diseases
|
Concept
|
Lipopolysaccharides
|
Concept
|
Neuroprotective Agents
|
Concept
|
Translocation, Genetic
|
Concept
|
Cricetulus
|
Concept
|
Anti-Inflammatory Agents, Non-Steroidal
|
Concept
|
Hydrocortisone
|
Concept
|
Nerve Net
|
Concept
|
Dietary Carbohydrates
|
Concept
|
Genetic Predisposition to Disease
|
Concept
|
Disease Management
|
Concept
|
Filamins
|
Concept
|
Anticonvulsants
|
Concept
|
Glioma
|
Concept
|
Dose-Response Relationship, Drug
|
Concept
|
Iron
|
Concept
|
Infant Formula
|
Concept
|
Amyloid
|
Concept
|
Obesity
|
Concept
|
Logistic Models
|
Concept
|
Dystonia
|
Concept
|
Protein Synthesis Inhibitors
|
Concept
|
Radioimmunoassay
|
Concept
|
Mental Recall
|
Concept
|
Mice
|
Concept
|
Language
|
Concept
|
Indans
|
Concept
|
Arrhythmias, Cardiac
|
Concept
|
Clinical Trials as Topic
|
Concept
|
Haploinsufficiency
|
Concept
|
DNA Primers
|
Concept
|
Excitatory Amino Acid Antagonists
|
Concept
|
Receptors, Metabotropic Glutamate
|
Concept
|
Factor Analysis, Statistical
|
Concept
|
Baclofen
|
Concept
|
Immunoenzyme Techniques
|
Concept
|
Models, Biological
|
Concept
|
Plasma Membrane Neurotransmitter Transport Proteins
|
Concept
|
Statistics, Nonparametric
|
Concept
|
Michigan
|
Concept
|
Hearing Loss, High-Frequency
|
Concept
|
Real-Time Polymerase Chain Reaction
|
Concept
|
Linear Models
|
Concept
|
Sympathetic Nervous System
|
Concept
|
Hypersensitivity
|
Concept
|
Primary Cell Culture
|
Concept
|
Point Mutation
|
Concept
|
Clonidine
|
Concept
|
Databases as Topic
|
Concept
|
Polymerase Chain Reaction
|
Concept
|
Apomorphine
|
Concept
|
Hippocampus
|
Concept
|
United States
|
Concept
|
Central Nervous System Agents
|
Concept
|
Morpholines
|
Concept
|
Vaccination
|
Concept
|
Parkinson Disease
|
Concept
|
United States Food and Drug Administration
|
Concept
|
Nervous System Malformations
|
Concept
|
Gene Deletion
|
Concept
|
Cholesterol
|
Concept
|
Risk Assessment
|
Concept
|
In Situ Hybridization, Fluorescence
|
Concept
|
Delivery of Health Care
|
Concept
|
Mutation, Missense
|
Concept
|
Risk
|
Concept
|
Gangliosides
|
Concept
|
Risk Factors
|
Concept
|
Signal-To-Noise Ratio
|
Concept
|
Apolipoprotein E3
|
Concept
|
Promoter Regions, Genetic
|
Concept
|
Nootropic Agents
|
Concept
|
Apolipoprotein E2
|
Concept
|
Gene Duplication
|
Concept
|
Enkephalins
|
Concept
|
Receptors, Opioid, delta
|
Concept
|
Base Sequence
|
Concept
|
Personality Assessment
|
Concept
|
Follow-Up Studies
|
Concept
|
Carbidopa
|
Concept
|
Zebrafish
|
Concept
|
Diffusion Tensor Imaging
|
Concept
|
Amyloid beta-Peptides
|
Concept
|
Genes, Homeobox
|
Concept
|
Siblings
|
Concept
|
Glial Cell Line-Derived Neurotrophic Factor Receptors
|
Concept
|
Immunohistochemistry
|
Concept
|
Adaptation, Psychological
|
Concept
|
Receptors, sigma
|
Concept
|
Acyltransferases
|
Concept
|
ROC Curve
|
Concept
|
Neurotransmitter Agents
|
Concept
|
Mice, Mutant Strains
|
Concept
|
Antidepressive Agents
|
Concept
|
Frameshift Mutation
|
Concept
|
Brain-Derived Neurotrophic Factor
|
Concept
|
Prostaglandins
|
Concept
|
Congresses as Topic
|
Concept
|
Myotonin-Protein Kinase
|
Concept
|
Mitral Valve Prolapse
|
Concept
|
Neuronal Plasticity
|
Concept
|
Proton-Translocating ATPases
|
Concept
|
Cerebral Cortex
|
Concept
|
Seizures
|
Concept
|
Treatment Failure
|
Concept
|
Mutagenesis, Insertional
|
Concept
|
Glucosamine
|
Concept
|
Thyrotropin
|
Concept
|
Embryonic and Fetal Development
|
Concept
|
Videotape Recording
|
Concept
|
Mice, Inbred C57BL
|
Concept
|
Chromosomes, Human, Pair 9
|
Concept
|
Mosaicism
|
Concept
|
Ganglioneuroma
|
Concept
|
Palate
|
Concept
|
Retrospective Studies
|
Concept
|
Repetitive Sequences, Nucleic Acid
|
Concept
|
Maze Learning
|
Concept
|
Health Policy
|
Concept
|
Glial Cell Line-Derived Neurotrophic Factors
|
Concept
|
Psychomotor Agitation
|
Concept
|
DNA Repeat Expansion
|
Concept
|
Platelet Count
|
Concept
|
Sequence Deletion
|
Concept
|
Neonatal Screening
|
Concept
|
Gait Disorders, Neurologic
|
Concept
|
Brain Mapping
|
Concept
|
Oligonucleotides
|
Concept
|
MEF2 Transcription Factors
|
Concept
|
Tyrosine
|
Concept
|
Mice, Transgenic
|
Concept
|
Physicians
|
Concept
|
Chromatography, Thin Layer
|
Concept
|
Class I Phosphatidylinositol 3-Kinases
|
Concept
|
Animals, Genetically Modified
|
Concept
|
Huntington Disease
|
Concept
|
Zebrafish Proteins
|
Concept
|
Sinus Arrest, Cardiac
|
Concept
|
Decision Support Techniques
|
Concept
|
Receptor, Metabotropic Glutamate 5
|
Concept
|
Receptors, Cholecystokinin
|
Concept
|
Quality of Life
|
Concept
|
Transforming Growth Factor beta1
|
Concept
|
Chromosomes, Human, Pair 22
|
Concept
|
Neuroblastoma
|
Concept
|
Adenosine
|
Concept
|
Serotonin Plasma Membrane Transport Proteins
|
Concept
|
Heart Rate
|
Concept
|
Orexin Receptors
|
Concept
|
Facies
|
Concept
|
Dopamine Agonists
|
Concept
|
Bile Acids and Salts
|
Concept
|
Spiperone
|
Concept
|
Lithium Carbonate
|
Concept
|
Severity of Illness Index
|
Concept
|
RNA, Messenger
|
Concept
|
Protein Structure, Secondary
|
Concept
|
Glutathione Transferase
|
Concept
|
Space Perception
|
Academic Article
|
The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period.
|
Academic Article
|
Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease.
|
Academic Article
|
Intrastriatal CERE-120 (AAV-Neurturin) protects striatal and cortical neurons and delays motor deficits in a transgenic mouse model of Huntington's disease.
|
Academic Article
|
Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease.
|
Academic Article
|
Update on the Clinical, Radiographic, and Neurobehavioral Manifestations in FXTAS and FMR1 Premutation Carriers.
|
Academic Article
|
Sudden infant death syndrome: case-control frequency differences at genes pertinent to early autonomic nervous system embryologic development.
|
Academic Article
|
Fragile X-associated tremor/ataxia syndrome in sisters related to X-inactivation.
|
Academic Article
|
Facial phenotype in children and young adults with PHOX2B-determined congenital central hypoventilation syndrome: quantitative pattern of dysmorphology.
|
Academic Article
|
Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial.
|
Academic Article
|
Genetic variation analysis in parkinson disease patients with and without hallucinations: case-control study.
|
Academic Article
|
Tremor and ataxia in fragile X premutation carriers: blinded videotape study.
|
Academic Article
|
Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results.
|
Academic Article
|
Cognitive trajectories in rare neurogenetic diseases: minding the gaps and filling the potholes.
|
Academic Article
|
Absence of mutations in HCRT, HCRTR1 and HCRTR2 in patients with ROHHAD.
|
Academic Article
|
Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back.
|
Academic Article
|
White matter disease and cognitive impairment in FMR1 premutation carriers.
|
Academic Article
|
Mechanism-based treatments in neurodevelopmental disorders: fragile X syndrome.
|
Academic Article
|
The challenges of clinical trials in fragile X syndrome.
|
Academic Article
|
Outcome measures for clinical trials in fragile X syndrome.
|
Academic Article
|
Analysis of PAC1 receptor gene variants in Caucasian and African American infants dying of sudden infant death syndrome.
|
Academic Article
|
Development of a genomic DNA reference material panel for myotonic dystrophy type 1 (DM1) genetic testing.
|
Academic Article
|
Development of an expressive language sampling procedure in fragile X syndrome: a pilot study.
|
Academic Article
|
Fragile X syndrome and targeted treatment trials.
|
Academic Article
|
Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation: analysis of hypothalamic and autonomic candidate genes.
|
Academic Article
|
Autonomic regulation in fragile X syndrome.
|
Academic Article
|
Evidence of mitochondrial dysfunction in fragile X-associated tremor/ataxia syndrome.
|
Academic Article
|
Congenital central hypoventilation syndrome from past to future: model for translational and transitional autonomic medicine.
|
Academic Article
|
HTR2A variation and sudden infant death syndrome: a case-control analysis.
|
Academic Article
|
Genetic variation in the HTR1A gene and sudden infant death syndrome.
|
Academic Article
|
CGG repeat length correlates with age of onset of motor signs of the fragile X-associated tremor/ataxia syndrome (FXTAS).
|
Academic Article
|
Nicotine metabolizing genes GSTT1 and CYP1A1 in sudden infant death syndrome.
|
Academic Article
|
Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder.
|
Academic Article
|
A comparative study of the performance of individuals with fragile X syndrome and Fmr1 knockout mice on Hebb-Williams mazes.
|
Academic Article
|
A comparative neuropsychological test battery differentiates cognitive signatures of Fragile X and Down syndrome.
|
Academic Article
|
Prepulse inhibition in fragile X syndrome: feasibility, reliability, and implications for treatment.
|
Academic Article
|
Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disorders.
|
Academic Article
|
Cognitive and visual processing skills and their relationship to mutation size in full and premutation female fragile X carriers.
|
Academic Article
|
Overexpression of fragile X gene (FMR-1) transcripts increases cAMP production in neural cells.
|
Academic Article
|
Carnitine levels and the ketogenic diet.
|
Academic Article
|
Stable expression and heterologous coupling of the kappa opioid receptor in cell lines of neural and nonneural origin.
|
Academic Article
|
Heterologous expression of the serotonin 5-HT1A receptor in neural and non-neural cell lines.
|
Academic Article
|
Neuromodulator-mediated phosphorylation of specific proteins in a neurotumor hybrid cell line (NCB-20).
|
Academic Article
|
Differential regulation of multiple neuroreceptors in a somatic cell hybrid by inhibitors of glycoprotein processing.
|
Academic Article
|
Possible role of gangliosides in regulating an adenylate cyclase-linked 5-hydroxytryptamine (5-HT1) receptor.
|
Academic Article
|
Evidence for [D-Ala2,D-Leu5]enkephalin-induced supersensitivity to 5-hydroxytryptamine in a neurotumor x brain hybrid cell line (NCB-20).
|
Academic Article
|
Gangliosides as modulators of the coupling of neurotransmitters to adenylate cyclase.
|
Academic Article
|
Characterization of an adenylate cyclase-linked serotonin (5-HT1) receptor in a neuroblastoma X brain explant hybrid cell line (NCB-20).
|
Academic Article
|
Modulation of an adenylate cyclase-linked serotonin (5-HT) receptor system in a neuroblastoma x brain explant hybrid cell line (NCB-20) by opiates, prostaglandins, and alpha 2-adrenergic agonists.
|
Academic Article
|
New Pvu II mitochondrial polymorphism in a mother and son of Indian ancestry.
|
Academic Article
|
Congenital central hypoventilation syndrome: Severe disease caused by co-occurrence of two PHOX2B variants inherited separately from asymptomatic family members.
|
Academic Article
|
Preventive care services and health behaviors in children with fragile X syndrome.
|
Academic Article
|
Improving the Diagnosis of Autism Spectrum Disorder in Fragile X Syndrome by Adapting the Social Communication Questionnaire and the Social Responsiveness Scale-2.
|
Academic Article
|
A Unique Visual Attention Profile Associated With the FMR1 Premutation.
|
Academic Article
|
Is FMR1 CGG Repeat Number Polymorphism Associated With Phenotypic Variation in the General Population? Report From a Cohort of 5,499 Adults.
|
Academic Article
|
Parent-reported measure of repetitive behavior in Phelan-McDermid syndrome.
|
Academic Article
|
A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX).
|
Academic Article
|
Lymphocytic Extracellular Signal-Regulated Kinase Dysregulation in Autism Spectrum Disorder.
|
Concept
|
Walk Test
|
Concept
|
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
|
Concept
|
Walking Speed
|
Concept
|
2-Hydroxypropyl-beta-cyclodextrin
|